FORTE BIOSCIENCES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $29.69 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $29.69.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.74.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-03-31 was $25.61, a 15.41% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2021-03-31 was $22.19.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $18.62, a 83.77% decline from fiscal 2024.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $114.74, a 1861.37% increase from fiscal 2023.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $5.85, a 78.16% decline from fiscal 2022.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $26.78, a 0.68% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.69 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $29.69 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $18.62 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $24.16 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $32.92 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $114.74 10-K · filed 2025-03-28 | |||
| 2024-09-30 | $129.00 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $5.16 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $2.74 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | $5.85 10-K · filed 2024-03-18 | |||
| 2022-12-31 | $26.78 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $30.10 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $31.80 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $25.61 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $26.60 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $24.09 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $21.46 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $22.19 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | $9.59 10-K · filed 2021-03-16 | |||
| 2020-09-30 | $9.59 10-Q · filed 2020-11-09 |